Polianta Ltd’s Cardinal Health CAH Stock Holding History

Polianta Ltd’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-15,700	Closed	-$1.13M	–	73
2016 Q4	$1.13M	Buy	+15,700	New	+$1.14M	0.61%	39

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

Polianta Ltd's CAH Position: Q1 2017 in Review

Polianta Ltd sold out of Cardinal Health (CAH) in Q1 2017, closing a stake of 15,700 shares — an estimated $1.13M sold.

Polianta Ltd first reported a position in CAH in Q4 2016 and held it in 1 quarter. The position peaked at $1.13M in Q4 2016. 767 funds tracked by Wall St. Rank hold CAH as of Q1 2017.

Polianta Ltd reported no remaining Cardinal Health position as of Q1 2017 after selling out during the quarter.
Polianta Ltd sold 15,700 Cardinal Health shares in Q1 2017, an estimated $1.13M.
Polianta Ltd first reported a position in Cardinal Health in Q4 2016 and held it in 1 quarter.
Polianta Ltd's Cardinal Health position peaked at $1.13M in Q4 2016.
767 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2017.

Based on Polianta Ltd's 13F filing for Q1 2017, filed 11 Apr 2017.